3.13
Active Transport
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct…
Active transport is the process of moving lipid-insoluble molecules against their concentration gradient using energy and specialized transporters.
There are two main types: primary and secondary active transport.
In primary transport, the Na+, K+- ATPase pump expels three sodium ions and moves two potassium ions into cells using ATP. Drugs such as digoxin can inhibit these pumps in the heart, elevating intracellular sodium levels to mitigate heart failure.
An ABC transporter, P-glycoprotein, spends ATP transporting various drugs out of enterocytes into the GI lumen, limiting their absorption.
In secondary transport, the movement of one molecule along its concentration gradient drives the transport of another molecule against its concentration gradient. This can occur through a symport or an antiport.
In a symport, both molecules move in the same direction, whereas in an antiport, one molecule moves in, and the other moves out of the cell.
View the full transcript and gain access to JoVE Core videos
Q1: What is active transport and how does it differ from passive movement?
Active transport moves lipid-insoluble molecules against their concentration gradient using energy and specialized transporters. Unlike passive diffusion, active transport requires ATP or an electrochemical gradient to function. This process is selective, saturable, and susceptible to competitive inhibition, making it essential for moving substances cells cannot transport passively.
Q2: How does the Na+, K+-ATPase pump work in primary active transport?
The Na+, K+-ATPase pump directly uses ATP to expel three sodium ions while moving two potassium ions into cells. This primary active transporter maintains cellular ion homeostasis. Digoxin inhibits this pump in cardiac cells, increasing intracellular sodium and enhancing calcium availability to improve heart muscle contractility in heart failure treatment.
Q3: What role does P-glycoprotein play in drug absorption?
P-glycoprotein is an ABC transporter that uses ATP to export various drugs out of enterocytes into the gastrointestinal lumen. This active transport mechanism significantly limits oral drug absorption by pumping drugs back into the GI tract. Understanding P-glycoprotein function is critical for predicting drug bioavailability and potential drug interactions.
Q4: How do symporters and antiporters differ in secondary active transport?
In secondary active transport, symporters move both molecules in the same direction, while antiporters move one molecule inward and another outward. The Na+-Ca2+ exchange protein (SLC8) is an antiporter that uses inward sodium flow to drive outward calcium flow, maintaining low cytosolic calcium levels. Symporters like CNT1 and neurotransmitter transporters move sodium and their substrates together.
Q5: What is the relationship between primary and secondary active transport?
Secondary active transporters depend on electrochemical gradients established by primary active transporters like the Na+, K+-ATPase pump. The sodium gradient created by primary transport powers secondary transporters to move solutes across membranes. This coupled mechanism allows cells to transport diverse substrates including drugs, neurotransmitters, and nucleosides efficiently.
Q6: How do neurotransmitter transporters use secondary active transport?
Neurotransmitter transporters like DAT, NET, and SERT are symporters that use the sodium gradient to move dopamine, norepinephrine, and serotonin into cells. These transporters harmonize sodium and neurotransmitter movement in the same direction. They have clinical significance as targets for CNS-active agents used in depression therapy and other neurological treatments.
Q7: Why is active transport important for drug pharmacokinetics?
Active transport mechanisms directly influence drug absorption, distribution, and elimination. Transporters like P-glycoprotein limit oral drug bioavailability by exporting drugs from enterocytes. Understanding active transport selectivity, saturation, and competitive inhibition is essential for predicting drug interactions, optimizing dosing strategies, and developing effective pharmaceutical therapies.